BSGM - Rasio utang marang kapitalisasi buku Biosig Technologies

Logo korporat perusahaan BioSig Technologies, Inc. (BSGM)

The debt-to-market cap dynamics correlate with the dependence of equipment procurement on clinic capital budgets, with the indicator currently standing at 0.00. The business stability of Biosig Technologies (BSGM) is underpinned by the rare expertise of its signal processing engineers. The financial profile of Biosig Technologies (BSGM) is shielded by the diplomatic neutrality of the biomedical sector, which minimizes geopolitical risks and guarantees asset resilience.

BioSig Technologies Inc. - Utang-utang marang kapitalisasi buku BSGM (periode 04.07.2022 - 12.09.2025)
Barang unggulan BioSig Technologies

To build a high-quality portfolio, I evaluate the stability of the issuer's capital structure. This metric compares total liabilities to the book value of equity to measure the level of debt load. For Biosig Technologies (BSGM), this balance is critical when scaling sales of PUREEP systems for cardiology. Analyzing the total debt-to-book equity ratio allows for an assessment of the business's financial autonomy. This chart's dynamics determine the degree of risk when investing in the company's technological growth.

Pesaing Biosig Technologies

DXCM: Utang-utang marang kapitalisasi buku|penumbrainc.com - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Novanta (NOVT)|HAE - Rasio utang marang aset resik|INSP: Utang-utang marang kapitalisasi buku|PRCT (Procept) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku CONMED Corporation CNMD|Rasio utang-utang marang kapitalisasi buku pulsebiosciences.com|InMode - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Picard Medical Corp PMI|Utang marang nilai buku SRDX (Surmodics Corp)|SENS - Utang-utang marang kapitalisasi buku|Utang marang nilai buku NeuroPace, Inc. NPCE|TCMD - Utang marang modal buku|SANUWAVE - Utang-utang marang kapitalisasi buku|Outset Medical Inc (OM) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku ELMD|Utang marang nilai buku LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Utang marang nilai buku|Rasio utang marang aset resik PROF (profoundmedical.com)|Baird Medical - Rasio utang marang kapitalisasi buku|Utang marang nilai buku EDAP TMS SA EDAP|APYX (Bovie Medical) - Utang-utang marang kapitalisasi buku|ICCM - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku pulmonx.com|TELA Bio (TELA) - Rasio utang marang nilai buku|CTSO: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Sensus Healthcare Inc|Utang-utang marang kapitalisasi buku ZYXI (Zynex Inc)|Utang marang nilai buku electrocore.com (ECOR)|Utang-utang marang kapitalisasi buku RBOT (Vicarious Surgical)|Inspira Technologies Oxy B.H.N. Ltd. - Utang-utang marang kapitalisasi buku|ICU - Rasio utang marang kapitalisasi buku|IRIDEX Corporation (IRIX) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku ibs.inc INBS|Beyond Air (XAIR) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku PFSA (Profusa Inc)|Utang-utang marang nilai buku SSKN|GCTK: Rasio utang marang kapitalisasi buku|Utang marang aset resik NanoVibronix Inc. NAOV|Utang marang nilai buku VERO (Venus Concept Corp)|Utang-utang marang kapitalisasi buku Nuwellis Corp NUWE|Utang-utang marang kapitalisasi buku AEMD (Aethlon Medical)|ASXC: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Avinger (AVGR)|CUTR (Cutera Inc.) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku KNW|Utang marang nilai buku Inari Medical Corp|Nevro Corp. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku RSLS (reshapelifesciences.com)|SILK - Rasio utang marang kapitalisasi buku